Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-14-052249
Filing Date
2014-08-13
Accepted
2014-08-13 18:41:54
Documents
1
Period of Report
2014-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7326
  Complete submission text file 0001209191-14-052249.txt   8766
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2401 FOURTH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Bencich John (Reporting) CIK: 0001477056 (see all company filings)

Type: 4/A | Act: 34 | File No.: 033-80623 | Film No.: 141038908